Effects of nifedipine and Bay K 8644 on the R-PIA and caffeine-induced changes in the locomotor activity of rats

Pharmacological Research

Volumn 33, Issue 2, 1996, Pages 141-144

  Erog̃lu, Lütfiye ^a   Tuna, R ^a   Caglayan B ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Bay K 8644; Caffeine; Locomotor activity; Nifedipine; R PIA

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; ADENOSINE; ADENOSINE DERIVATIVE; ADENOSINE RECEPTOR BLOCKING AGENT; CAFFEINE; CALCIUM CHANNEL; NIFEDIPINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030087540     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1996.0021     Document Type: Article

References (30)

1. 1. Dunwiddie TV, Proctor WR. Mechanisms underlying physiological responses to adenosine in the central nervous system. In: Gerlach E, Becker BF, eds. Topics and perspectives in adenosine research. Berlin, Heidelberg, New York: Springer, 1987: 499-507.
2. 2. Fredholm BB, Fastbon J, Lindgren E. Effects of N-ethyl-maleimide and forskolin on glutamate release from rat hippocampal slices. Evidence that prejunctional adenosine receptors are linked to N-proteines, but not to adenylate cyclase. Acta Physiol Scand 1986; 127: 381-6.
3. 1 receptors in rat brain synaptosomes: transductional mechanisms, effects on glutamate release, and preservation after metabolic inhibition. Drug Devel Res 1995; 35: 119-29.
4. 45Ca uptake by synaptosomes stimulated by potassium. Biochem Pharmacol 1979; 28: 1297-300.
5. 5. Murphy KMM, Snyder SH. Adenosine receptor binding and specific receptors for calcium channel drugs. In: Merril GF, Weiss HR, eds. Calcium entry blockers, adenosine and neurohumors: Advances in coronary vascular and cardiac control, Baltimore: Urban and Schwarzenberg, 1982: 295-306.
6. 3H)nitrobenzylthioinosine binding to the adenosine transporter in human brain. Eur J Pharmacol 1993; 238: 131-3.
7. 7. Marangos PJ, Finkel MS, Verma A, Maturi MF, Patel J, Patterson RE. Adenosine uptake sites in dog heart and brain; interaction with calcium antagonists. Life Sci 1984; 35: 1109-6.
8. 8. Phillis JW, Swanson TH, Barraco RA. Interactions between adenosine and nifedipine in rat cerebral cortex. Neurochem Int 1984; 6: 693-9.
9. 9. Burnstock G. Physiological and pathological roles of purines: an update. Drug Develop Res 1993; 28: 195-206.
10. 10. Dunwiddie TV, Worth T. Sedative and anticonvulsant effects of adenosine analogs in mouse and rat. J Pharmacol Exp Ther 1982; 220: 70-6.
11. 11. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobsen KA, Leff P, Williams M. Nomenclature and classification of purinoceptors. Pharmacol Rev 1994; 46: 143-56.
12. 2 selective adenosine agonists and antagonists: evidence for synergism and antagonism. J Pharmacol Exp Ther 1991; 259: 286-94.
13. 13. Virus RM, Ticho S, Pilditch M, Radulovacki M. A comparison of the effects of caffeine, 8-cyclopentyltheophylline, and alloxazine on sleep in rats. Neuropsychopharmacol 1990; 3: 243-9.
14. 2-mediated behavior in short term reserpinized mice. Eur J Pharmacol 1991; 192: 25-30.
15. 15. Zarrindast MR, Adeli R, Semnani SH, Sharifzadeh M. Effects of adenosine receptor agonists and antagonists on physostigmine induced yawning. Eur J Pharmacol 1995; 276: 1-7.
16. 3 adenosine receptors mediation of behavioral depressant effects. FEBS 1993; 336, 1: 57-60.
17. 17. Snyder SH, Katinis JJ, Annau Z, Bruns RF, Daly JW. Adenosine receptors and behavioral actions of methylxantines. Proc Natl Acad Sci USA 1981; 78: 3260-4.
18. 18. Buckholtz NS, Middaugh LD. Effects of caffeine and L-phenylisopropyladenosine on locomotor activity of mice. Pharmacol Biochem Behav 1987; 28: 179-85.
19. 19. Clark M, Dar MS. Mediation of acute ethanol induced motor disturbances by cerebellar adenosine in rats. Pharmacol Biochem Behav 1988; 30: 155-61.
20. 20. Nehlig A, Daval JL, Debry G. Caffeine and central nervous system: mechanisms of action, biochemical, metabolic and psycho stimulant effects. Brain Res Rev 1992; 17: 139-70.
21. 21. File SE, Baldwin HA, Johnston AL, Wilks LJ. Behavioral effects of acute and chronic administration of caffeine in the rat. Pharmacol Biochem Behav 1988; 30: 809-15.
22. 22. Kaplan GB, Tai NT, Greenblat DJ, Shader RI. Caffeine induced behavioral stimulation is dose- and concentration-dependent. Br J Pharmacol 1990; 100: 435-40.
23. 1 adenosine receptor occupancy. Neuropsychopharmacol 1992; 6: 145-53.
24. 24. Ferré S, Marschitz MH, Anden MG, Casas M, Ungerstedt U, Anden NE. Postsynaptic dopamine/ adenosine interaction: 2. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short term reserpinized mice. Eur J Pharmacol 1991; 192: 31-7.
25. 25. Ungerstedt U. Central dopamine mechanisms and unconditioned behaviour. In: The neurobiology of dopamine, eds. Horn AS, Korf J, Westerink BHC. Academic Press, London, New York, San Francisco; 1979; 577.
26. 26. Speddings M, Kilpatrick AT, Alps BJ. Activators and inactivators of calcium channels: effects in the central nervous system. Fund Clin Pharmacol 1989; 3: 3s-29s.
27. 27. Fredholm BB, Hu PS, Lindgren E. The dihydropyridine calcium channel agonist Bay K 8644 inhibits the presynaptic effects of R-phenylisopropyl adenosine in the rat hippocampus. Acta Physiol Scand 1986; 128: 659-60.
28. 3H)nitrendipine binding sites in rat brain: localization to synaptic zones. Eur J Pharmacol 1982; 81: 351-5.
29. 29. Phillis JW, Wu PH. Adenosine and benzodiazepine action. In: Usdin E, Tallman JF, Greenblat D, Paul SM, eds. The pharmacology of benzodiazepines, New York: Macmillan, 1982: 497-502.
30. 30. Hopkins SV. The potentiation of the action of adenosine on the guinea-pig heart. Biochem Pharmacol 1973; 22: 341-8.